![Cynthia Marina Giuliani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cynthia Marina Giuliani
Nessuna posizione attualmente
Storia della carriera di Cynthia Marina Giuliani
Precedenti posizioni note di Cynthia Marina Giuliani
Società | Posizione | Inizio | Fine |
---|---|---|---|
Liebert Hiross SpA | Corporate Officer/Principal | 01/01/2000 | 01/01/2002 |
BioXell SpA
![]() BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | Ufficiale delle Risorse Umane | - | - |
MOLMED S.P.A. | Ufficiale delle Risorse Umane | 01/02/2008 | - |
Formazione di Cynthia Marina Giuliani
University of the Witwatersrand | Undergraduate Degree |
Statistiche
Distribuzione geografica
Italia | 4 |
Sud Africa | 2 |
Posizioni
Human Resources Officer | 2 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
BioXell SpA
![]() BioXell SpA BiotechnologyHealth Technology BioXell SpA provides medical services. The company researches and develops drugs to treat urological, inflammatory, and related disorders. The company was founded in 2002 and is headquartered in Segrate, Italy. | Health Technology |
AGC Biologics SpA
![]() AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
Liebert Hiross SpA |